Literature DB >> 8554025

Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis.

M E Fawzy1, L Mimish, V Sivanandam, J Lingamanaicker, A Patel, B Khan, C M Duran.   

Abstract

The pulmonary vascular hemodynamics were studied in 21 patients with severe mitral stenosis and severe pulmonary hypertension. Hemodynamic data were obtained before and immediately after mitral balloon valvotomy (MBV) and at follow-up 7 to 14 months (mean 12 months) later by repeat catheterization. The mean pulmonary capillary wedge pressure (PCW) decreased from 27 +/- 5 to 15 +/- 4 mm Hg (p < 0.001). The mean mitral valve gradient (MVG) decreased from 18 +/- 4 to 6 +/- 2 mm Hg (p < 0.001). Mitral valve area (MVA) increased from 0.6 +/- 0.1 to 1.5 +/- 0.3 cm2 (p < 0.02). Cardiac index increased from 2.2 +/- 0.3 to 2.6 to 0.5 L/min/m2 (p < 0.02). The pulmonary artery systolic pressure decreased from 65 +/- 13 to 50 +/- 13 mm Hg (p < 0.001), and no significant change was seen in pulmonary vascular resistance (PVR) immediately after MBV from 461 +/- 149 to 401 +/- 227 dynes/sec/cm(-5) (p = 0.02). At follow-up the MVA increased from 1.5 +/- 0.3 to 1.7 +/- 0.3 cm2 (p < 0.02). Cardiac index increased further to 3 +/- 0.4 L/min/m2 (p < 0.02). MVG and PCW pressure remained the same. The pulmonary artery systolic pressure decreased further to 38 +/- 9 mm Hg (p < 0.02). PVR decreased significantly to 212 +/- 99 dynes/sec/cm(-5) (p < 0.02). We concluded that the pulmonary artery pressure decreased without normalizing immediately after MBV and normalized in patients with optimal results from mitral balloon valvotomy 7 to 14 months later. Insignificant change in PVR was seen immediately after MBV and markedly decreased or normalized at late follow-up in patients with optimal result from MBV.

Entities:  

Mesh:

Year:  1996        PMID: 8554025     DOI: 10.1016/s0002-8703(96)90055-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Pulmonary vascular pressure profiles in broilers selected for susceptibility to pulmonary hypertension syndrome: age and sex comparisons.

Authors:  R F Wideman; M L Eanes; K R Hamal; N B Anthony
Journal:  Poult Sci       Date:  2010-09       Impact factor: 3.352

2.  Echocardiographic pattern and severity of valve dysfunction in children with rheumatic heart disease seen at Uganda Heart Institute, Mulago hospital.

Authors:  Sulaiman Lubega; Twalib Aliku; Peter Lwabi
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

3.  Long term clinical and echocardiographic results of mitral balloon valvotomy in children and adolescents.

Authors:  M E Fawzy; M A Stefadouros; H Hegazy; F E Shaer; M A Chaudhary; F A Fadley
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 4.  Pulmonary hypertension caused by pulmonary venous hypertension.

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

5.  Mitral balloon valvuloplasty.

Authors:  Mohamed Eid Fawzy
Journal:  J Saudi Heart Assoc       Date:  2010-05-11

6.  Pulmonary blood flow and pulmonary hypertension: Is the pulmonary circulation flowophobic or flowophilic?

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

7.  Persistent pulmonary artery hypertension in patients undergoing balloon mitral valvotomy.

Authors:  Krishna Kumar Mohanan Nair; Harikrishnan Sivadasan Pillai; Thomas Titus; Ajitkumar Varaparambil; Sivasubramonian Sivasankaran; Kavassery Mahadevan Krishnamoorthy; Narayanan Namboodiri; Bijulal Sasidharan; Anees Thajudeen; Sanjay Ganapathy; Jaganmohan Tharakan
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

8.  Left Ventricular Remodeling Following Balloon Mitral Valvuloplasty in Rheumatic Mitral Stenosis: Magnetic Resonance Imaging Study.

Authors:  Amir Anwar Samaan; Karim Said; Wafaa El Aroussy; Mohammed Hassan; Soha Romeih; Amr El Sawy; Mohammed Eid Fawzy; Magdi Yacoub
Journal:  Front Cardiovasc Med       Date:  2021-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.